USD 0.0
(25.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 603 Thousand | 547.47 Thousand | 951.75 Thousand | 498.63 Thousand | 962.21 Thousand | 993.16 Thousand |
Selling, General and Administrative Expenses | 603 Thousand | 547.47 Thousand | 951.75 Thousand | 498.63 Thousand | 962.21 Thousand | 993.16 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 603 Thousand | 547.47 Thousand | 951.75 Thousand | 498.63 Thousand | 962.21 Thousand | 993.16 Thousand |
Operating Income | -603 Thousand | -547.47 Thousand | -951.75 Thousand | -498.63 Thousand | -962.21 Thousand | -993.16 Thousand |
Interest Expense | 88.35 Thousand | 82.16 Thousand | 88.69 Thousand | 60.44 Thousand | - | - |
Income Tax Expense | - | -593.00 | -956.00 | -494.00 | -960.00 | -1.84 Million |
Earnings before Tax | -387 Thousand | -114.48 Thousand | -851.09 Thousand | -1.74 Million | -818.88 Thousand | -1.15 Million |
Net Income | -387 Thousand | -114.48 Thousand | -851.09 Thousand | -1.74 Million | -818.88 Thousand | -1.15 Million |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 436.26 Million | 409.74 Million | 381.26 Million | 339.39 Million | 334.56 Million | 300.21 Million |
Weighted Average Shares Outstanding (Diluted) | 436.26 Million | 409.74 Million | 381.26 Million | 339.39 Million | 334.56 Million | 300.21 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -295.82 Thousand | - | - | - | 141.11 Thousand | 847 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 34.99 Thousand | 49.77 Thousand | 94.54 Thousand | 598.59 Thousand | -4936.51 | 168.19 Thousand |
Selling, General and Administrative Expenses | 34.99 Thousand | 49.77 Thousand | 94.54 Thousand | - | -4936.51 | 168.19 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 34.99 Thousand | 49.77 Thousand | 94.54 Thousand | 598.59 Thousand | -4936.51 | 168.19 Thousand |
Operating Income | -34.99 Thousand | -49.77 Thousand | -94.54 Thousand | -598.59 Thousand | 4939.23 | -168.19 Thousand |
Interest Expense | 22 Thousand | 22 Thousand | 23.63 Thousand | 88.35 Thousand | 22.7 Thousand | 22.29 Thousand |
Income Tax Expense | -35 Thousand | - | -92.06 | -603.00 | -191.00 | -167.00 |
Earnings before Tax | -56.98 Thousand | -56.74 Thousand | -92.48 Thousand | -384.17 Thousand | 14.8 Thousand | -68.89 Thousand |
Net Income | -56.98 Thousand | -56.74 Thousand | -92.48 Thousand | -384.17 Thousand | 15 Thousand | -68.89 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | - | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | - | -0.00 |
Weighted Average Shares Outstanding | 436.26 Million | 436.26 Million | 436.26 Million | 436.26 Million | 436.26 Million | 436.26 Million |
Weighted Average Shares Outstanding (Diluted) | 436.26 Million | 436.26 Million | 436.26 Million | 436.26 Million | 436.26 Million | 436.26 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -34.99 Thousand | -49.77 Thousand | -94.54 Thousand | - | 4939.23 | -168.19 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
010120
IGG
GOTU
AMPY
BIOAF
XOM